Type 2 diabetes (T2D) is a heterogeneous disease, yet current classifications do not capture its clinico-biological complexity or support precision-based care. We developed an endotyping strategy based on routine blood immune cell counts across more than 1,500 individuals with newly diagnosed T2D from three European co...
B. Vuong, Chloe Delepine, Jacqueline M. Ratter-Rieck et al.· Cell Metabolism· 0 citations
Limited data exist on the relationship of resting heart rate (RHR) and heart rate variability (HRV) indices with cardiovascular (CVD) and coronary heart disease (CHD) mortality in individuals with and without (pre)diabetes. We investigated overall and glucose tolerance status-specific association of RHR and a large num...
K. Oluwagbemigun, Dan Ziegler, Alexander Strom et al.· Scientific Reports· 0 citations
The need for therapeutic strategies beyond conventional risk factor modification, with emphasis on acute hemodynamic management, tailored pharmacotherapy, and optimized glycemic control in this high-risk population of individuals with established diabetes is highlighted.
R. Ipek, Edyta Schaefer, M. Neuenschwander et al.· Pharmacology and Therapeutic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.